Keryx Biopharmaceuticals (KERX) Stock: Announces FDA Approval | Falling On Poor Earnings

Keryx Biopharmaceuticals (NASDAQ: KERX) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company released its earnings for the third quarter, missing expectations. While the company also announced that the FDA has approved one of its treatment candidates, investor concerns with regard to earnings seem to be … Read more

Keryx Biopharmaceuticals (KERX) Stock: Gaining On Insurance Coverage News

Keryx Biopharmaceuticals (NASDAQ:KERX) is having an incredibly strong start to the day in the pre-market hours this morning, and for good reason. The company released positive news with regard to insurance coverage. Of course, this led to excitement among investors, sending the stock upward and prompting our partners at Trade Ideas to send the alert. … Read more

Keryx Biopharmaceuticals (KERX) Stock: Halted Just Before PDUFA

Keryx Biopharmaceuticals (NASDAQ: KERX) Keryx Biopharmaceuticals was off to an incredibly strong start to the trading session today. However, the shares have been halted and news is pending. Today, we’ll talk about what we’ve seen from the stock thus far today, why the halt may have happened, and what we’ll be watching for from KERX … Read more

As The Dow Continues On Declines These Biotechs Offer Hope: MannKind (MNKD), Arrowhead Research (ARWR), Keryx Biopharmaceuticals (KERX)

The Dow Jones and the rest of the US market is, and has been, having a rough time. In fact, for months now, we’ve seen nothing, but declines in the market. However, there is one industry that’s presenting gems as of late. That’s the biotech industry! Today, we’ll talk about why US markets are falling … Read more

Keryx Biopharmaceuticals (KERX) Climbs On European Approval

Keryx Biopharmaceuticals (NASDAQ: KERX) Keryx Biopharmaceuticals is having a great day in the market today after announcing that the European Commission has made the decision to approve Fexeric. Today, we’ll talk about what Fexeric is, what European approval means for KERX, how the market reacted to the news and what we can expect to see … Read more

Keryx Biopharmaceuticals Stock Climbs | Can It Last?

Keryx Biopharmaceuticals (NASDAQ: KERX) Following recent declines, Keryx Biopharmaceuticals is having a great day in the market today. However, the big question is, can the climb last? So today, we’ll take a look at what’s causing the stock to jump, see how high it’s gotten so far, and discuss whether or not the uptrends are … Read more